Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models

Despite the recent advances in the treatment of ovarian cancer, it remains an area of high unmet medical need. Epithelial ovarian cancer is associated with high levels of mesothelin expression, and therefore, mesothelin is an attractive candidate target for the treatment of this disease. Herein, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Quanz, Maria, Hagemann, Urs B., Zitzmann-Kolbe, Sabine, Stelte-Ludwig, Beatrix, Golfier, Sven, Elbi, Cem, Mumberg, Dominik, Ziegelbauer, Karl, Schatz, Christoph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183338/
https://www.ncbi.nlm.nih.gov/pubmed/30344925
http://dx.doi.org/10.18632/oncotarget.26135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183338/
https://www.ncbi.nlm.nih.gov/pubmed/30344925
http://dx.doi.org/10.18632/oncotarget.26135

Ejemplares similares